Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
576.49
-7.21 (-1.24%)
At close: Dec 3, 2025, 4:00 PM EST
577.00
+0.51 (0.09%)
Pre-market: Dec 4, 2025, 7:04 AM EST
Medpace Holdings Employees
Medpace Holdings had 5,900 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
5,900
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$399,724
Profits / Employee
$73,377
Market Cap
16.24B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5,900 | 0 | - |
| Dec 31, 2023 | 5,900 | 700 | 13.46% |
| Dec 31, 2022 | 5,200 | 700 | 15.56% |
| Dec 31, 2021 | 4,500 | 900 | 25.00% |
| Dec 31, 2020 | 3,600 | 100 | 2.86% |
| Dec 31, 2019 | 3,500 | 600 | 20.69% |
| Dec 31, 2018 | 2,900 | 400 | 16.00% |
| Dec 31, 2017 | 2,500 | 0 | - |
| Dec 31, 2016 | 2,500 | 300 | 13.64% |
| Dec 31, 2015 | 2,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MEDP News
- 6 days ago - Wasatch Global Opportunities Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 15 days ago - 6 Healthcare Stocks With Strong Upward Momentum - Benzinga
- 5 weeks ago - Why Medpace Popped 13% This Week - The Motley Fool
- 5 weeks ago - Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings - Benzinga
- 5 weeks ago - Medpace: Full CRO Model Builds Net Revenue Growth, Maintain At Strong Buy - Seeking Alpha
- 5 weeks ago - Medpace Holdings, Inc. (MEDP) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins - Benzinga
- 5 weeks ago - Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back - Barrons